vs

Side-by-side financial comparison of FARMERS & MERCHANTS BANCORP INC (FMAO) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $32.5M, roughly 1.5× FARMERS & MERCHANTS BANCORP INC). FARMERS & MERCHANTS BANCORP INC runs the higher net margin — 30.2% vs -4.8%, a 34.9% gap on every dollar of revenue. On growth, FARMERS & MERCHANTS BANCORP INC posted the faster year-over-year revenue change (21.0% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $35.0M). Over the past eight quarters, FARMERS & MERCHANTS BANCORP INC's revenue compounded faster (16.1% CAGR vs -20.2%).

Rainier Bancorporation was the Seattle-based parent corporation of Rainier National Bank, a Washington state bank with branches throughout the state. Rainier traced its roots back to the National Bank of Commerce, which was founded by Richard Holyoke in 1889. The name Rainier National Bank was adopted in 1974. Rainier Bancorp expanded into Alaska with the purchase of Anchorage's People's Bank & Trust in 1983 and into Oregon with the purchase of Gresham's Mount Hood Security Bank in 1986, expa...

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

FMAO vs IRWD — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.5× larger
IRWD
$47.7M
$32.5M
FMAO
Growing faster (revenue YoY)
FMAO
FMAO
+68.3% gap
FMAO
21.0%
-47.3%
IRWD
Higher net margin
FMAO
FMAO
34.9% more per $
FMAO
30.2%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$39.6M more FCF
IRWD
$74.6M
$35.0M
FMAO
Faster 2-yr revenue CAGR
FMAO
FMAO
Annualised
FMAO
16.1%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FMAO
FMAO
IRWD
IRWD
Revenue
$32.5M
$47.7M
Net Profit
$9.8M
$-2.3M
Gross Margin
Operating Margin
39.5%
14.3%
Net Margin
30.2%
-4.8%
Revenue YoY
21.0%
-47.3%
Net Profit YoY
16.8%
-200.9%
EPS (diluted)
$0.72
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FMAO
FMAO
IRWD
IRWD
Q4 25
$32.5M
$47.7M
Q3 25
$31.3M
$122.1M
Q2 25
$29.6M
$85.2M
Q1 25
$28.1M
$41.1M
Q4 24
$26.8M
$90.5M
Q3 24
$25.5M
$91.6M
Q2 24
$25.1M
$94.4M
Q1 24
$24.1M
$74.9M
Net Profit
FMAO
FMAO
IRWD
IRWD
Q4 25
$9.8M
$-2.3M
Q3 25
$8.9M
$40.1M
Q2 25
$7.7M
$23.6M
Q1 25
$7.0M
$-37.4M
Q4 24
$8.4M
$2.3M
Q3 24
$6.5M
$3.6M
Q2 24
$5.7M
$-860.0K
Q1 24
$5.4M
$-4.2M
Operating Margin
FMAO
FMAO
IRWD
IRWD
Q4 25
39.5%
14.3%
Q3 25
35.9%
61.8%
Q2 25
32.7%
53.2%
Q1 25
31.2%
-70.7%
Q4 24
39.2%
34.8%
Q3 24
31.7%
28.0%
Q2 24
28.5%
26.5%
Q1 24
28.2%
14.7%
Net Margin
FMAO
FMAO
IRWD
IRWD
Q4 25
30.2%
-4.8%
Q3 25
28.3%
32.8%
Q2 25
26.0%
27.7%
Q1 25
24.8%
-90.9%
Q4 24
31.2%
2.5%
Q3 24
25.5%
4.0%
Q2 24
22.6%
-0.9%
Q1 24
22.3%
-5.6%
EPS (diluted)
FMAO
FMAO
IRWD
IRWD
Q4 25
$0.72
$0.01
Q3 25
$0.64
$0.23
Q2 25
$0.56
$0.14
Q1 25
$0.51
$-0.23
Q4 24
$0.61
$0.03
Q3 24
$0.48
$0.02
Q2 24
$0.42
$-0.01
Q1 24
$0.39
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FMAO
FMAO
IRWD
IRWD
Cash + ST InvestmentsLiquidity on hand
$215.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$370.9M
$-261.8M
Total Assets
$3.4B
$396.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FMAO
FMAO
IRWD
IRWD
Q4 25
$215.5M
Q3 25
$140.4M
Q2 25
$92.9M
Q1 25
$108.5M
Q4 24
$88.6M
Q3 24
$88.2M
Q2 24
$105.5M
Q1 24
$121.5M
Total Debt
FMAO
FMAO
IRWD
IRWD
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
Q2 24
$198.6M
Q1 24
$398.3M
Stockholders' Equity
FMAO
FMAO
IRWD
IRWD
Q4 25
$370.9M
$-261.8M
Q3 25
$361.8M
$-264.2M
Q2 25
$350.8M
$-308.2M
Q1 25
$344.6M
$-334.1M
Q4 24
$335.2M
$-301.3M
Q3 24
$335.4M
$-311.3M
Q2 24
$322.7M
$-321.7M
Q1 24
$317.7M
$-330.5M
Total Assets
FMAO
FMAO
IRWD
IRWD
Q4 25
$3.4B
$396.9M
Q3 25
$3.4B
$396.1M
Q2 25
$3.3B
$342.9M
Q1 25
$3.4B
$327.2M
Q4 24
$3.4B
$350.9M
Q3 24
$3.4B
$389.5M
Q2 24
$3.3B
$395.6M
Q1 24
$3.3B
$438.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FMAO
FMAO
IRWD
IRWD
Operating Cash FlowLast quarter
$36.7M
$74.6M
Free Cash FlowOCF − Capex
$35.0M
$74.6M
FCF MarginFCF / Revenue
107.8%
156.3%
Capex IntensityCapex / Revenue
5.4%
0.0%
Cash ConversionOCF / Net Profit
3.75×
TTM Free Cash FlowTrailing 4 quarters
$56.7M
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FMAO
FMAO
IRWD
IRWD
Q4 25
$36.7M
$74.6M
Q3 25
$11.2M
$47.6M
Q2 25
$1.1M
$-15.1M
Q1 25
$11.0M
$20.0M
Q4 24
$32.5M
$15.2M
Q3 24
$18.7M
$9.9M
Q2 24
$9.7M
$33.5M
Q1 24
$1.5M
$45.0M
Free Cash Flow
FMAO
FMAO
IRWD
IRWD
Q4 25
$35.0M
$74.6M
Q3 25
$10.7M
$47.6M
Q2 25
$385.0K
$-15.1M
Q1 25
$10.6M
$19.9M
Q4 24
$30.6M
Q3 24
$18.3M
$9.9M
Q2 24
$9.2M
$33.4M
Q1 24
$1.3M
$44.9M
FCF Margin
FMAO
FMAO
IRWD
IRWD
Q4 25
107.8%
156.3%
Q3 25
34.3%
39.0%
Q2 25
1.3%
-17.7%
Q1 25
37.8%
48.4%
Q4 24
114.1%
Q3 24
71.7%
10.8%
Q2 24
36.5%
35.4%
Q1 24
5.3%
60.0%
Capex Intensity
FMAO
FMAO
IRWD
IRWD
Q4 25
5.4%
0.0%
Q3 25
1.5%
0.0%
Q2 25
2.4%
0.0%
Q1 25
1.4%
0.1%
Q4 24
7.0%
0.0%
Q3 24
1.4%
0.0%
Q2 24
2.3%
0.1%
Q1 24
0.9%
0.1%
Cash Conversion
FMAO
FMAO
IRWD
IRWD
Q4 25
3.75×
Q3 25
1.26×
1.19×
Q2 25
0.14×
-0.64×
Q1 25
1.58×
Q4 24
3.87×
6.74×
Q3 24
2.86×
2.71×
Q2 24
1.71×
Q1 24
0.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons